Search - tctmd.com

Displaying 21 - 29 of 29

Sort: Relevancy | Date

News Industry News

Risk of late stent thrombosis continues for up to seven years in patients with first generation drug-eluting stents; risk factors identified

November 08, 2011

News Industry News

Medtronic Resolute(R) Drug-Eluting Stent Shows Strong Results, Even in Challenging Diabetes Patients with Coronary Disease

November 07, 2011

News Industry News

FDA Advisory Panel Makes Recommendation on Investigational Medtronic Phased RF Ablation System for Treatment of Persistent or Long-Standing Persistent Atrial Fibrillation

October 27, 2011

News Industry News

Resverlogix Expands Phase 2b Program with the Commencement of Dosing in SUSTAIN

September 27, 2011

News Industry News

InspireMD Enrolls First Patient in the MASTER (MGuard for Acute ST Elevation Reperfusion) Randomized Trial

July 26, 2011

News Industry News

InspireMD Enrolls First Patient in the MASTER (MGuard for Acute ST Elevation Reperfusion) Randomized Trial

July 26, 2011

News Industry News

Boston Scientific Completes Clinical Trial Enrollment for Adapt™ Monorail™ Carotid Stent System

July 12, 2011

News Industry News

Medtronic Resolute® Drug-Eluting Stent Exhibits Strong Safety Profile in Broad Spectrum of Patients

May 20, 2011

News Industry News

Medtronic Resolute® Drug-Eluting Stent Offers Strong Performance in Diabetic Patients with Heart Disease

May 18, 2011

Advertisement

Risk of late stent thrombosis continues for up to seven years in patients with first generation drug-eluting stents; risk factors identified

Medtronic Resolute(R) Drug-Eluting Stent Shows Strong Results, Even in Challenging Diabetes Patients with Coronary Disease

FDA Advisory Panel Makes Recommendation on Investigational Medtronic Phased RF Ablation System for Treatment of Persistent or Long-Standing Persistent Atrial Fibrillation

Resverlogix Expands Phase 2b Program with the Commencement of Dosing in SUSTAIN

InspireMD Enrolls First Patient in the MASTER (MGuard for Acute ST Elevation Reperfusion) Randomized Trial

InspireMD Enrolls First Patient in the MASTER (MGuard for Acute ST Elevation Reperfusion) Randomized Trial

Boston Scientific Completes Clinical Trial Enrollment for Adapt™ Monorail™ Carotid Stent System

Medtronic Resolute® Drug-Eluting Stent Exhibits Strong Safety Profile in Broad Spectrum of Patients

Medtronic Resolute® Drug-Eluting Stent Offers Strong Performance in Diabetic Patients with Heart Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content